ABBOTT LABORATORIES · News & developments
Abbott received FDA approval for TactiFlex Duo catheter
Source: TradingViewBullish
Abbott received FDA approval for its TactiFlex Duo catheter, according to the 9 September 2026 headline. The approval expands Abbott’s cleared product portfolio in catheter-based care.
Why this matters
A new approved device can support future revenue and improve Abbott’s growth mix, but the headline does not disclose launch timing, pricing, adoption or expected earnings contribution. Those unknowns limit the immediate valuation impact.